CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
Erchonia PL2000 +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00929305
NCT00929305N/ACompleted

Study of the Effect of Low Level Laser Therapy on the Reduction of Chronic Pain Associated With Neck and Shoulder Pain of Musculoskeletal Origin.

Erchonia Corporation·interventional·Posted Jun 29, 2009·Updated Apr 21, 2014

In Brief

A clinical study evaluating Erchonia PL2000 and Placebo laser for Shoulder Pain and 4 related conditions. Completed, enrolled 100 participants.

Detailed Summary

The purpose of this study was to determine whether the application of low level laser light therapy to the neck and shoulder region is effective in reducing chronic neck and shoulder pain of musculoskeletal origin.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
Countries--
Collaborators--

Timeline

N/ACompletedFinished
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 29, 2009
Enrollment StartJan 1, 2001
Primary CompletionJun 1, 2001
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 17.0 years ago

Interventions

Erchonia PL2000device

The Erchonia PL2000 Laser emits 1 mW of red (635nm wavelength) light via an electric diode energy source. It is a hand-held device that uses rechargeable batteries or a separate power adapter.

Placebo laserdevice

Inactive laser light